Mounjaro vs Bydureon

Quick Facts

  • Type: GLP-1/GIP vs GLP-1
  • FDA Approval: Mounjaro (2022), Bydureon (2012)
  • Frequency: Once weekly

Weight Loss Data

  • Mounjaro: 15-20% in 72 weeks
  • Bydureon: 2-4% in 24 weeks

Primary Uses

  • Type 2 Diabetes
  • Weight Management
  • Blood Sugar Control

Medication Overview

Mounjaro

GLP-1/GIP

Basic Information

  • Generic Name: tirzepatide
  • Manufacturer: Eli Lilly
  • FDA Approval: 2022

Key Benefits

  • Superior A1C reduction compared to other GLP-1s
  • Significant weight loss potential
  • Dual-action mechanism
  • Once-weekly dosing

Bydureon

GLP-1

Basic Information

  • Generic Name: exenatide extended-release
  • Manufacturer: AstraZeneca
  • FDA Approval: 2012

Key Benefits

  • Once-weekly dosing
  • No dose titration needed
  • Steady medication levels
  • Established safety profile

Dosing Information

Dosing DetailsMounjaroBydureon
Starting Dose2.5mg2mg
Maintenance Dose5mg to 10mg2mg
Maximum Dose15mg2mg
ScheduleInject once weekly at any time of dayInject once weekly at any time of day
TitrationStart with 2.5mg for 4 weeks, then increase to 5mg. Can increase by 2.5mg every 4 weeksNo titration required, fixed 2mg dose

Side Effects

Mounjaro

  • Nausea
  • Diarrhea
  • Decreased Appetite
  • Vomiting
  • Constipation
  • Indigestion

Bydureon

  • Nausea
  • Diarrhea
  • Headache
  • Vomiting
  • Constipation
  • Injection Site Reactions

Practical Information

Mounjaro

Storage & Handling

  • Storage: Refrigerate until first use, then can be stored at room temperature for up to 21 days
  • Needle Info: Comes with attached hidden needle

Insurance & Coverage

Growing coverage for diabetes, may require prior authorization

Clinical Results

  • Weight Loss: 15-20%
  • Study Duration: 72 weeks
  • Study: SURMOUNT-1 trial

Bydureon

Storage & Handling

  • Storage: Refrigerate until use, do not freeze
  • Needle Info: Comes with needles in kit

Insurance & Coverage

Generally covered for diabetes treatment

Clinical Results

  • Weight Loss: 2-4%
  • Study Duration: 24 weeks
  • Study: DURATION clinical trials

Medical Disclaimer: This comparison is for informational purposes only and should not replace professional medical advice. Always consult with your healthcare provider about which medication is right for you. Treatment decisions should be based on your individual medical needs and circumstances.

ShotWise App Interface

Track Your GLP-1 Journey with ShotWise

Get personalized dose tracking, side effect monitoring, and weight loss progress tracking all in one place. Join thousands of others managing their GLP-1 medications effectively.

Download ShotWise